Nombre de los medicamentos: Genérico y Comercial – Aprenda acerca de las causas, los síntomas, el diagnóstico y el tratamiento de los Manuales MSD. Se ha demostrado que los antibióticos aplicados en el párpado alivian los síntomas y resuelven la infección bacteriana de los párpados. Contraindicadas en casos de hipersensibilidad a cualquiera de los antibióticos del grupo de la neomicina (aminoglucósidos), ya que existe sensibilización.
|Published (Last):||22 July 2004|
|PDF File Size:||13.6 Mb|
|ePub File Size:||19.4 Mb|
|Price:||Free* [*Free Regsitration Required]|
Quantitaty eye lid evaluation of anophthalmic cavity carriers with external ocular prosthesis. Clinical qntibioticos status of bacterial conjunctivitis at Visits 2 Day 34 Day 8and 5 Day 12 in the study eye 3. Review by the Competent Authority or Ethics Committee in the country concerned. Sujetos de cualquier edad en la visita 1 Nota: Expanded clinical resolution status, defined as a global clinical score of 0, 1, or 2 with neither injection nor discharge having a score of 2, at Visits 2 Day 33 Day 54 Day 8and 5 Day 12 in the study eye 8.
The global clinical score defined as the sum of bulbar conjunctival injection and ocular conjunctival discharge and change from baseline in the global clinical score at Visits 2 Day 33 Day 54 Day antibiotivosand 5 Day 12 in the study eye 6. Clear advanced search filters.
Committee on Advanced therapies CAT has issued a classification for this product.
The primary objective of this study is to evaluate the efficacy of SHP based on clinical resolution defined as absence of bulbar conjunctival injection and oftakmicos conjunctival discharge compared with placebo in the treatment of subjects with bacterial conjunctivitis in the study eye at Visit 3 Day 5.
Presence of any significant ophthalmic condition eg, Retinopathy of Prematurity, congenital cataract, congenital glaucoma or other congenital disorder with ophthalmic involvement that could affect study variables.
Tener un herpes ocular activo o antecedente. Absolute and change from baseline of the individual clinical signs bulbar conjunctival injection and ocular conjunctival discharge at Visits 2 Day 33 Day 54 Day 8and 5 Day 12 in the study eye 5. Have active or a history of ocular herpes.
Allergic conjunctivitis and conjunctival retraction are the most frequent illnesses in the patients wearing ocular prosthesis for more than one year, due to Staphylococcus aureus presence resulting from frequent hygienic handling of the prosthesis.
Clinical Trials Register
Similarly, most of the anophthalmic cavities are atypical in adults with loss of eyeball from traumatism. The majority of patients positively responded to treatment. Time to clinical resolution based upon assessments at Visits 2 Day 33 Day 54 Day 8and 5 Day 12 in the study eye 9. Current or relevant history of physical or psychiatric illness, any medical disorder that may make the subject unlikely to fully complete the study, or any condition that presents undue risk from the investigational product or procedures.
Presence of nasolacrimal duct obstruction at Visit 1 Day 1. Have a preplanned overnight hospitalization during the period of the study. EU Clinical Trials Register. Modified clinical resolution status, defined as a global clinical score of 0 or 1, at Visits 2 Day 33 Day 54 Day 8and 5 Day 12 in the study eye 7. The IMP has been designated in this indication as an orphan drug in the Community. The trial involves single site in the Member State concerned.
For these items you should use the filters and not add them to your search terms in the text field. Age, sex, causes of eye loss, affected eye, conjunctival disease, type of cavity, length of time of prosthesis use, microbiological result, hygienic handling and response to treatment were the analyzed variables.
The key secondary objective of this study is to evaluate the efficacy of SHP based on bacterial eradication defined as absence of all bacterial species present at or above pathological threshold at baseline compared with placebo in the treatment of subjects with bacterial conjunctivitis in the study eye at Visit 3 Day 5.
IMP with orphan designation in the indication. Have a history of recurrent corneal erosion syndrome, either idiopathic or secondary ogtalmicos previous corneal trauma or dry eye syndrome; presence of corneal epithelial defect or any significant corneal opacity at Visit 1. Title of the trial for lay people, in easily understood, i.
Presence of significant, active condition in the posterior segment that requires invasive treatment eg, intravitreal treatment with antibiotjcos endothelial growth factor inhibitors or corticosteroids and may progress during the study participation period. Have any known clinically significant optic nerve defects. Neonates or infants ie.
Uso de medicamentos de rescate.
Full list pftalmicos Inclusion criteria can be found in the protocol. Bacterial eradication status defined as absence of all bacterial species present at or above pathological threshold at baseline in the study eye at Visit 3 Day 5 between SHP and placebo. Trials with results Trials without results.
Nicodemo D, Ferreira LM. Use of rescue medication Safety Endpoints: Clinical trials The European Union Clinical Trials Register allows you to search for protocol and results information on: Definition of the end of the trial and justification where it is not the last visit of the last subject undergoing the trial. How to search [pdf]. Conocimiento, capacidad y voluntad para cumplir plenamente con los procedimientos y restricciones del estudio por los progenitores, tutor o representante legal autorizado, si procede.
Tener una enfermedad ocular significativa p.
Le siguen, en orden de frecuencia, las infecciones y el glaucoma. Key Secondary Efficacy Endpoints: Aantibioticos 3 Day 5 2. Questionnaire of the psychosocial profile of the patient with anophthalmia with indication antibiotiicos ocular prosthesis.
Full list of Exclusion criteria can be found in the protocol. Date on which this record was first entered in the EudraCT database:. Trials with results Trials without results Clear advanced search filters. Cancer AND drug name. Plans for treatment or care after the subject has ended the participation in the trial if it is different from the expected normal treatment of that condition.
Las secreciones toman por esta causa un color verde-azuloso. Arch Soc Esp Oftalmol.